Euglena Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 1,042

Employees

  • Stock Symbol
  • 2931

Stock Symbol

  • Investments
  • 24

  • Share Price
  • $1.96
  • (As of Friday Closing)

Euglena General Information

Description

euglena Co Ltd is a biotechnology company that researches, develops, produces, and markets microalgae. The company focuses on commercializing its algae research for a variety of uses, including functional foods and cosmetics. Euglena also researches ways to use its microalgae for carbon capture and biofuel production. The company operates in three segments: Healthcare Business, Biofuel Business, and Other Businesses.

Contact Information

Website
www.euglena.jp
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • G-Base Tamachi 2nd Floor
  • 5-29-11 Shiba, Minato-ku
  • Tokyo, 108-0014
  • Japan
+81
Primary Industry
Biotechnology
Stock Exchange
TKS
Vertical(s)
Corporate Office
  • G-Base Tamachi 2nd Floor
  • 5-29-11 Shiba, Minato-ku
  • Tokyo, 108-0014
  • Japan
+81

Euglena Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Euglena Stock Performance

As of 13-Nov-2026, Euglena’s stock price is $1.96. Its current market cap is $274M with 140M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.96 $1.96 $1.92 - $2.97 $274M 140M 661K

Euglena Financials Summary

As of 30-Sep-2026, Euglena has a trailing 12-month revenue of $338M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 331,128 382,060 400,650 649,065
Revenue 338,339 336,546 314,417 330,809
EBITDA 37,583 24,853 9,501
Net Income (1,061) (5,379) (4,292) (18,874)
Total Assets 431,665 462,401 466,509 422,740
Total Debt 137,260 176,952 165,045 177,771
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Euglena Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Euglena‘s full profile, request access.

Request a free trial

Euglena Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
euglena Co Ltd is a biotechnology company that researches, develops, produces, and markets microalgae. The company focus
Biotechnology
Tokyo, Japan
1,042 As of 2025

Chassieu, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Euglena Competitors (1)

One of Euglena’s competitors is Amoeba, a Formerly VC-backed company based in Chassieu, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amoeba Formerly VC-backed Chassieu, France
You’re viewing 1 of 1 competitors. Get the full list »

Euglena Patents

Euglena Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026146738-A Composition Pending 04-Mar-2025
JP-2026129051-A Cosmetics Pending 30-Jan-2025
JP-2026092444-A Fuel oil containing 50% to 90% by volume of hydrogenated vegetable oil Pending 26-Nov-2024
JP-2026080528-A Device for detecting target substance and use thereof Pending 31-Oct-2024
JP-2026032430-A Method for selecting microorganism for high sugar yield Pending 13-Aug-2024
To view Euglena’s complete patent history, request access »

Euglena Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Euglena Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Euglena‘s full profile, request access.

Request a free trial

Euglena Investments & Acquisitions (24)

Euglena’s most recent deal was a Merger/Acquisition with Jeffer (Beverages). The deal was made on 05-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Jeffer (Beverages) 05-Jan-2026 Merger/Acquisition Beverages
Joint Venture (Petronas / Eni / Euglena) 26-Jul-2024 Joint Venture Energy Exploration
Satis Pharmaceutical 10-Jan-2024 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Aqua Theon 21-Nov-2023 Early Stage VC Food Products
Hako (Media and Information Services (B2B)) 01-Jul-2022 Merger/Acquisition Media and Information Services (B2B)
You’re viewing 5 of 24 investments and acquisitions. Get the full list »

Euglena ESG

Risk Overview

Risk Rating

Updated November, 08, 2026

35.21 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Household Products

Industry

of 104

Rank

Percentile

Personal Products

Subindustry

of 84

Rank

Percentile

To view Euglena’s complete esg history, request access »

Euglena Exits (2)

Euglena’s most recent exit was on 15-May-2018 from Medcare. The exit was categorized as with 8 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Medcare 15-May-2018 Completed
  • 8 buyers
Amelieff 31-Jan-2016 Corporate Completed
To view Euglena’s complete exits history, request access »

Euglena Affiliates

Subsidiaries (10)

Name Industry Location Year Founded
CQ Ventures Fukuoka, Japan 2016
Hako (Media and Information Services (B2B)) Tokyo, Japan 2015
Genequest Tokyo, Japan 2013
Mej Tokyo, Japan 2008
Satis Pharmaceutical Yoshikawa, Japan 1999
You’re viewing 5 of 10 affiliates. Get the full list.  »

Euglena FAQs

  • When was Euglena founded?

    Euglena was founded in 2005.

  • Where is Euglena headquartered?

    Euglena is headquartered in Tokyo, Japan.

  • What is the size of Euglena?

    Euglena has 1,042 total employees.

  • What industry is Euglena in?

    Euglena’s primary industry is Biotechnology.

  • Is Euglena a private or public company?

    Euglena is a Public company.

  • What is Euglena’s stock symbol?

    The ticker symbol for Euglena is 2931.

  • What is the current stock price of Euglena?

    As of 13-Nov-2026 the stock price of Euglena is $1.96.

  • What is the current market cap of Euglena?

    The current market capitalization of Euglena is $274M.

  • What is Euglena’s current revenue?

    The trailing twelve month revenue for Euglena is $338M.

  • Who are Euglena’s competitors?

    Amoeba is a competitor of Euglena.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process